BATM Advanced Communications Ltd (LON:BVC) target price maintained at 20.00GBX, reported earlier today by finnCap
- Updated: September 18, 2016
BATM Advanced Communications Ltd (LON:BVC) had its target price hold steady to 20GBX by finnCap in an issued report issued 8/15/2016. The updated target price indicates a potential upside of 0.05% based on the company’s most recent closing price.
Yesterday BATM Advanced Communications Ltd (LON:BVC) traded 0.70% lower at 19.00GBX. The company’s 50-day average is 17.96GBX and its 200-day average is 16.45GBX. The last stock price close is up 7.88% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Trading volume was was down over the average, with 18,321 shares of BVC changing hands under the typical 492,602 shares..
Recent Performance Graph:
BATM Advanced Communications Ltd has a one-year low of 12.54GBX and a one-year high of 20.75GBX . BATM Advanced Communications Ltd’s market cap is presently 0.0 GBX.
A total of 1 equity analyst has issued a report on BVC. Zero rate the stock a strong buy, 0 rate the company a buy, 0 analysts rate the company a hold, 0 rate the company to underperform, and finally 0 brokeragesrate the company as sell with a 12-month target price of 0.27GBX
About BATM Advanced Communications Ltd (LON:BVC)
BATM Advanced Communications Ltd. is an Israel-based company engaged in the development, production and marketing of medical products, as well as data communication products. The Company has two operating divisions: Telecommunications and BATM Medical. The Telecommunications division develops and offers telecom network solutions, IP surveillance solutions, software services and Cyber Security solutions. The Telecommunications offers its products to telecom operators in developed markets. BATM Medical is a manufacturer and developer of laboratory diagnostics, including in-vitro diagnostic systems and reagents to detect viral infections, to diagnose immune system diseases and for the measurement of human hormone responses. BATM Medical, which focuses on developing countries in Eastern Europe and Asia, also manufactures sterilizers and medical waste management solutions, and and distributes brands of other diagnostic equipment suppliers to emerging market countries.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.